2015-05-302011-12-14SANTOS, Olimpia Maria Martins. Desenvolvimento e validação de metodologia analítica para análise de finasterida cápsulas. 2011. 96 f. Dissertação (Mestrado em Ciências Farmacêuticas) - Universidade Federal de Alfenas, Alfenas, MG, 2014.https://repositorio.unifal-mg.edu.br/handle/123456789/308Finasteride (FNS) is a synthetic drug 4-azasteróide (azaandrost-1-ene-17-carboxamide, N-(1,1-dimethyl)-3-oxo-, (5 , 17 ), specific inhibitor of steroid Type II , 5 -reductase, an intracellular enzyme that converts testosterone to the more potent androgen 5 -dihydrotestosterone. FNS is classified as Class II (low solubility and high permeability) Biopharmaceutical Classification System (BCS). FNS is indicated for the treatment and control men with benign prostatic hyperplasia (BPH), prevention and treatment of prostate cancer and androgenetic alopecia some cases of hirsutism. Although the compounded drugs offer advantages with respect to ease dosage and more affordable, there are many obstacles that hinder the advancement of industry manipulation. The largest of these obstacles is the lack of credibility of the product handled by the supposed absence of a strict quality control of raw materials and finished products, lack of control of the production process and its reproducibility. To achieve a therapeutic goal expected, it must be noted that the drug concentration is indicated by the manufacturer to release the principle active in adequate amount and speed the therapeutic effect. There is no official monograph for quantification of FNS as pharmaceutical capsules or dissolution test. Therefore, to develop an analytical methodology for quantification of FNS in compounded capsules, which is quick, precise and selective is of great importance to ensure that potential non conformities are detected in time to make corrective measures before they can entail risks for the patient, which can translate into inefficiency, toxicity, eventually, death. This work was developed and validated a rapid, precise, selective, stability indicator for the quantification of NSF in the form of capsules and a dissolution test for in vitro quantification of their release into the dissolution medium for the purpose of assessing the quality of these products in routine analysis laboratory quality control.application/pdfAcesso Abertohttp://creativecommons.org/licenses/by-nc-nd/4.0/FinasteridaCápsulasCromatografia liquida de alta eficienciaDissoluçãoControle de qualidadeFARMACIA::ANALISE E CONTROLE E MEDICAMENTOSDissertaçãoAraújo, Magali Benjamim De